Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
9 items
Fundus photo showing large white patches

Researchers discover new molecular driver of retinoblastoma

September 30, 2022

Study from UT Southwestern Medical Center could lead to new treatments for deadly childhood eye cancer.
Illustration of a woman wearing sunglasses and a hat.

Protecting your eyes from the sun’s UV light

July 5, 2022

Did you know the sun's ultraviolet (UV) rays can also damage the eyes? Here are some common questions and answers about UV light and how to protect your eyes from the sun.

NIH study confirms benefit of supplements for slowing age-related macular degeneration

June 2, 2022

The AREDS2 formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original formula.
Scientists in the laboratory

Retinoblastoma resource: Researchers create more accurate research model

August 6, 2021

Scientists at St. Jude Children’s Research Hospital have created a laboratory model for studying retinoblastoma driven by inherited mutations in the RB1 gene.
eye anatomy graphic

Melanoma of the eye: preclinical tests show path toward treatment

July 14, 2021

Researchers at UAB have discovered a small molecule inhibitor that dampens the potent drivers of uveal melanoma.
Image of brain cells with "sparks" of red and yellow

Brain tumors caused by normal neuron activity in mice predisposed to such tumors

May 26, 2021

A study by researchers at Washington University School of Medicine in St. Louis and Stanford University School of Medicine shows that the normal day-to-day activity of neurons can drive the formation and growth of brain tumors.

Therapy using immune system cells preserves vision in mice implanted with rare eye cancer

October 12, 2020

A treatment that uses immune system T-cells, combined with an immune-boosting drug packaged in an injectable gel, was found to preserve the vision of mice implanted with tissue from a human eye cancer known as retinoblastoma.
NEI logo.

Scientists Find Similar Survival Rates for Eye Cancer Therapies

July 12, 2001

Researchers have found that the survival rates for two alternative treatments for primary eye cancer–radiation therapy and removal of the eye–are about the same.
NEI logo.

Radiation Treatment for Eye Cancer Does Not Change Patients' Five-Year Survival

June 15, 1998

Researchers found that patients with large eye melanomas had similarfive-year survival rates regardless of whether they were treated withradiation prior to removal of the eye or had their eye removed withoutprior radiation therapy.